论文部分内容阅读
目的:观察健脾补肾法治疗原发性肝癌患者经导管动脉内化疗栓塞术后综合征的临床疗效。方法:将103例原发性肝癌患者随机分为2组,治疗组52例,对照组51例。治疗组术后第2天开始服用健脾补肾的中药煎剂,对照组术后仅予现代医学对症治疗。观察2组患者化疗栓塞术后综合征的症状持续时间、肝功能、中医证候疗效、Karnofsky评分情况等。结果:治疗组患者介入治疗后发热、肝区疼痛、恶心、呕吐、腹泻的持续时间,肝功能,Karnofsky评分情况,中医证候疗效与对照组比较,差异均有显著性意义(P<0.05)。结论:健脾补肾法对减轻肝癌化疗栓塞术后综合征有较好的临床疗效。
OBJECTIVE: To observe the clinical efficacy of transcatheter arterial chemoembolization (TAE) syndrome in patients with primary liver cancer treated with Jianpi Bushen method. Methods: 103 patients with primary liver cancer were randomly divided into 2 groups, 52 in the treatment group and 51 in the control group. The treatment group began to take the traditional Chinese medicine decoction of Jianpi Bushen on the 2nd day after the operation, and the control group received only the symptomatic treatment of modern medicine after the operation. The duration of symptoms, liver function, TCM syndrome efficacy, and Karnofsky score were observed in the two groups of patients after chemoembolization. Results: The patients in the treatment group had fever, liver pain, nausea, vomiting, duration of diarrhea, liver function, Karnofsky score, and the effect of TCM syndrome compared with the control group. There were significant differences (P<0.05). . Conclusion: The method of invigorating the spleen and tonifying the kidney has a good clinical effect in alleviating the postoperative chemoembolization syndrome of liver cancer.